Chelsea Richardson, PA
Physician Assistant · Papillion, NENPI 1255679726
Payments from drug & device makers
Across 161 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$549
- AbbVie$516
- Novo Nordisk$405
- Merck$87
- Amgen$77
- AstraZeneca$77
- plus $789 from 26 others
What the payments were for
- Food & beverage$2,45498%
- Education$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 35 | $549 |
| AbbVie | 31 | $516 |
| Novo Nordisk | 31 | $405 |
| Merck | 6 | $87 |
| Amgen | 5 | $77 |
| AstraZeneca | 5 | $77 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Johnson & Johnson | 4 | $72 |
| Bayer | 5 | $67 |
| Boehringer Ingelheim | 4 | $61 |
| Astellas Pharma US Inc | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Nestle Healthcare Nutrition Inc. | 2 | $38 |
| Ultragenyx Pharmaceutical Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| Gilead | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Abiomed | 1 | $22 |
| Abbott | 1 | $20 |
| Tonix Medicines, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
| GSK | 1 | $13 |
How this compares
$2,499 in reported general payments places this provider in the 85th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 27 | $28,113 |
| MounjaroTirzepatide | 21 | $21,952 |
| EliquisApixaban | 22 | $20,432 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $18,583 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $17,824 |
| FarxigaDapagliflozin Propanediol | 16 | $14,305 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $10,655 |
| MyrbetriqMirabegron | 18 | $8,379 |
| Novolog FlexpenInsulin Aspart | 14 | $4,524 |
| Potassium Chloride | 39 | $3,697 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,253 |
| SynthroidLevothyroxine Sodium | 15 | $1,661 |
| Atorvastatin Calcium | 162 | $1,199 |
| Bupropion XlBupropion Hcl | 38 | $1,073 |
| Omeprazole | 63 | $921 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $549 | $50,06548 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $13 | $31,49144 claims |
| AstraZenecaFarxiga | $77 | $14,30516 claims |
| Astellas Pharma US IncMyrbetriq | $58 | $8,37918 claims |
| AbbVieSynthroid | $516 | $1,66115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Papillion
- Katlin NadrchalPapillion$6K
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
- Laura TvrdyLincoln$13K
- Courtney MaresLincoln$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.